Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Duloxetine“
Suchtreffer
Begriffe & Kennungen
Duloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Serotonergic agents
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · The concomitant use of Duloxetine Viatris with selective, reversible MAOIs, like moclobemide, is not recommend
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · The risk of using duloxetine in combination with other CNS-active medicinal products has not been systematical
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 Undesirable effects · 1
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · 11 Very Common Uncommon Rare Very rare Not known common Nervous system disorders Headache Dizziness Myoclonus
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · 12 Very Common Uncommon Rare Very rare Not known common Hepato-biliary disorders Hepatitis3 Hepatic failure6 E
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · 13 Very Common Uncommon Rare Very rare Not known common General disorders and administration site conditions F
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · 14 was also a small increase in fasting blood glucose and in total cholesterol in duloxetine-treated patients
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · A total of 467 paediatric patients initially randomized to duloxetine in clinical trials, experienced a 0.1 kg
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · A total of 509 paediatric patients aged 7 to 17 years with major depressive disorder and 241 paediatric patien
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Description of selected adverse reactions
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Discontinuation of duloxetine (particularly when abrupt) commonly leads to withdrawal symptoms. Dizziness, sen
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Generally, for SSRIs and SNRIs, these events are mild to moderate and self-limiting, however, in some patients
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · In studies of up to 9 months an overall mean decrease of 1% in height percentile (decrease of 2% in children (
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain,
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Paediatric population
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Summary of the safety profile
Eintrag öffnen